Open AccessEffect of Silymarin (Milk Thistle) on Liver Disease in Patients With Chronic Hepatitis C Unsuccessfully Treated With Interferon Therapy
Author(s) -
Michael Fried,
Victor J. Navarro,
Nezam H. Afdhal,
Steven H. Belle,
Abdus S. Wahed,
Roy L. Hawke,
Edward Doo,
Catherine M. Meyers,
K. Rajender Reddy
Publication year - 2012
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2012.8265
Subject(s) - medicine , milk thistle , placebo , gastroenterology , liver disease , alanine transaminase , hepatitis c virus , immunology , traditional medicine , virus , pathology , alternative medicine
The botanical product silymarin, an extract of milk thistle, is commonly used by patients to treat chronic liver disease, despite scant and conflicting evidence of its efficacy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom